Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic Reportedly in Talks to Buy Insulin Pump Patch Maker Triple Jump

10/17/2021 EST

Medtronic plc (NYSE:MDT) is in talks to acquire Israeli insulin pump patch developer Triple Jump Israel Ltd. at a company valuation of $300 million. Triple Jump's small insulin pump patch for diabetes patients is designed to be placed on the patient’s body. The patch has mobile connectivity capabilities and will be included in a future artificial pancreas system - Medtronic has already developed such an artificial pancreas system and plans integrating Triple Jump's device into the system to improve its pumping capabilities.


ę S&P Capital IQ 2021
All news about MEDTRONIC PLC
11/28Vincent Medical Strikes Product Distribution Deal with NYSE-listed Medtronic; Shares Ra..
MT
11/24JPMorgan Adjusts Medtronic's Price Target to $130 from $148, Keeps Overweight Rating
MT
11/24Bernstein Adjusts Medtronic's Price Target to $143 from $148, Keeps Outperform Rating
MT
11/24Stifel Adjusts Medtronic's Price Target to $140 from $145, Keeps Buy Rating
MT
11/24Raymond James Adjusts Medtronic's Price Target to $127 from $142, Keeps Outperform Rati..
MT
11/24Truist Securities Adjusts Medtronic's Price Target to $142 from $148, Keeps Buy Rating
MT
11/24Wells Fargo Adjusts Medtronic's Price Target to $137 From $144, Reiterates Overweight R..
MT
11/24Oppenheimer Adjusts Price Target on Medtronic to $145 From $150, Maintains Outperform R..
MT
11/24Morgan Stanley Adjusts Price Target on Medtronic to $145 From $154, Maintains Overweigh..
MT
11/24Citigroup Adjusts Medtronic's Price Target to $146 From $153, Reiterates Buy Rating
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 396 M - -
Net income 2022 5 378 M - -
Net Debt 2022 22 296 M - -
P/E ratio 2022 28,4x
Yield 2022 2,26%
Capitalization 149 B 149 B -
EV / Sales 2022 5,30x
EV / Sales 2023 4,90x
Nbr of Employees 90 000
Free-Float 99,8%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 111,05 $
Average target price 141,32 $
Spread / Average Target 27,3%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC-5.20%149 347
ABBOTT LABORATORIES14.97%222 592
BECTON, DICKINSON AND COMPANY-2.05%69 611
HOYA CORPORATION27.96%59 428
DEXCOM, INC.60.11%57 374
SARTORIUS STEDIM BIOTECH76.99%53 762